Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Objectives To summarize quantitatively the literature comparing hypothalamic-pituitary-adrenal (HPA) axis function between depressed and nondepressed individuals and to describe the important sources of variability in this literature. These sources include methodological differences between studies, as well as demographic or clinical differences between depressed samples. Methods The current study used meta-analytic techniques to compare 671 effect sizes (cortisol, adrenocorticotropic hormone, or corticotropin-releasing hormone) across 361 studies, including 18,454 individuals. Results Although depressed individuals tended to display increased cortisol (d = 0.60; 95% confidence interval [CI], 0.54-0.66) and adrenocorticotropic hormone levels (d = 0.28; 95% CI, 0.16-0.41), they did not display elevations in corticotropin-releasing hormone (d = 0.02; 95% CI, -0.47-0.51). The magnitude of the cortisol effect was reduced by almost half (d = 0.33; 95% CI, 0.21-0.45) when analyses were limited to studies that met minimal methodological standards. Gender did not significantly modify any HPA outcome. Studies that included older hospitalized individuals reported significantly greater cortisol differences between depressed and nondepressed groups compared with studies with younger outpatient samples. Important cortisol differences also emerged for atypical, endogenous, melancholic, and psychotic forms of depression. Conclusions The current study suggests that the degree of HPA hyperact…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional studies on the pathological mechanism of depression have suggested that the HPA axis is hyperactive in MDD patients and that sensitivity to negative feedback is decreased. 15”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [15]
In the citing paper
“Chronic hyperactivation of the stress system is related to hypersecretion of corticotropin releasing hormone and arginine-vasopressin (CRH, AVP) by the hypothalamus and ACTH hypersecretion by the pituitary (76), resulting in higher circulating cortisol levels due also to an “insensitive” negative glucocorticoid (GC) feedback of the HPA axis loop (77).”
From Developmental Trajectories of Early Life Stress and Trauma: A Narrative Review on Neurobiological Aspects Beyond Stress System Dysregulation (2019) · cites this paper as [77]
In the citing paper
“A further metaanalysis of 18,374 adult individuals found higher cortisol in MDD when measured continuously throughout the day, with morning times revealing the least difference between the groups.”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“Post DST, higher cortisol and reduced ACTH were found with MDD compared to non-depressed in a metanalysis of 1,639 adults (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
In the citing paper
“ACTH was also higher overall in MDD patients; however, there was no difference between control and depressed patients at any one time of day (158).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [158]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Dickerson, S. S., & Kemeny, M. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.3.355 · Cited by 5,881
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
Fixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Miller, G. E., Chen, E., & Zhou, E. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.1.25 · Cited by 2,467 · cited 1×
“This is important because it is these processes, rather than increased cortisol levels, that are more closely linked to disease outcomes (18,35).”
BackgroundSelf-citationThe HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · cited 1×
“These individuals are, therefore, more likely to be at risk for conditions where excessive cortisol is thought to play a pathogenic role, such as Type II diabetes, osteoporosis, or dementia (33,34).”
BackgroundGold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Depression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194
Cited by
Items 101–200 of 1,305
The Bidirectional Relationship between Diabetes and Depression: A Literature Review
Alzoubi, A., Abunaser, R., Khassawneh, A., Alfaqih, M. A., Khasawneh, A. G., & Abdo, N. M. (2018) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2018.39.3.137 · Cited by 153
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Faye, C., McGowan, J. C., Denny, C. A., & David, D. J. P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170818095105 · Cited by 152
“A meta-analysis of 354 studies including 18,374 subjects across both depressed and control groups have reported greater cortisol levels in approximately two-thirds of depressed patients [155].”
BackgroundInsomnia and incident depression: role of objective sleep duration and natural history
Fernandez‐Mendoza, J., Shea, S., Vgontzas, A. N., Calhoun, S. L., Liao, D., & Bixler, E. O. (2015) · Journal of Sleep Research · doi:10.1111/jsr.12285 · Cited by 148
“Moreover, none of the previous studies examined possible mediating factors, for example stress response or coping resources (Healey et al., 1981; Kessler et al., 1985; Morin et al., 2003; Stetler and Miller, 2011), in the association of insomnia with incident depression (Baglioni et al., 2011).”
BackgroundInfluentialDepression and type 2 diabetes: A causal relationship and mechanistic pathway
Khawagi, W. Y., Al-Kuraishy, H. M., Hussein, N. R., Al-Gareeb, A. I., Atef, E., Elhussieny, O., Alexiou, A. T., Papadakis, M., Jabir, M. S., Alshehri, A. A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15630 · Cited by 151
“87 Various studies have shown blunted diurnal variation of cortisol levels in T2D patients.”
Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A., Lix, L. M., Hitchon, C. A., El-Gabalawy, R., et al. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000579 · Cited by 144
“Depression is known to induce changes in immune function, including immunosuppression and inflammation (Nair et al. 1999; Yeragani et al. 2000; Irwin & Miller, 2007), as well as hyperactivity of the hypothalamic pituitary axis (Stetler & Miller, 2011).”
BackgroundAtypical depression: current perspectives
Łojko, D., & Rybakowski, J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s147317 · Cited by 118
“35 A meta-analysis of studies on the HPA axis conducted by Stetler and Miller 45 has identified a pattern of relative hypocortisolemia in AD compared to the mel-ancholic spectrum of depressive disorders, but findings of other authors are inconsistent.”
Sun, P., Smith, A. S., Lei, K., Liu, Y., & Wang, Z. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.016 · Cited by 141
“Individuals with depression experience increased cortisol in circulation [99,100], CRH-expressing neurons in the PVN in depressed individuals [78], and synergetic interaction between CRH and AVP [78–80,101].”
BackgroundSchrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Penedo, F., Lucci, J. A., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.022 · Cited by 127
O’Keane, V., Frodl, T., & Dinan, T. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.009 · Cited by 140
Circulating cortisol and cognitive and structural brain measures: The Framingham Heart Study
Echouffo-Tcheugui, J. B., Conner, S. C., Himali, J. J., Maillard, P., DeCarli, C. S., Beiser, A. S., Vasan, R. S., & Seshadri, S. (2018) · Neurology · doi:10.1212/wnl.0000000000006549 · Cited by 139
The ceramide system as a novel antidepressant target
Kornhuber, J., Müller, C. P., Becker, K. A., Reichel, M., & Gulbins, E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.003 · Cited by 141
Mayer, S. E., Lopez-Duran, N. L., Sen, S., & Abelson, J. L. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.03.020 · Cited by 137
“Links between HPA axis hyperactivity and depression have been shown in studies using cortisol measures in blood, saliva, and urine (reviewed in Nemeroff and Vale, 2005), but great variability exists, depending on patient characteristics and clinical status or subtype (Lamers et al., 2013; Stetler and Miller, 2011).”
BackgroundKarb, R. A., Elliott, M. R., Dowd, J. B., & Morenoff, J. D. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.031 · Cited by 136
“…work with the larger CCHAS dataset found significant associations between neighborhood stressors, social support, and depressive symptoms (Mair, Diez Roux, & Morenoff, 2010), and there is evidence of a bi-directional relationship between depression and cortisol activity (Stetler & Miller, 2011).”
Depression: Biological markers and treatment
Nedic Erjavec, G., Sagud, M., Nikolac Perkovic, M., Svob Strac, D., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 119
Tyrka, A. R., Parade, S. H., Welch, E. S., Ridout, K. K., Price, L. H., Marsit, C., Philip, N. S., & Carpenter, L. L. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.112 · Cited by 135
Needham, B. L., Mezuk, B., Bareis, N., Lin, J., Blackburn, E. H., & Epel, E. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.89 · Cited by 125
Verduijn, J., Milaneschi, Y., Schoevers, R. A., van Hemert, A. M., Beekman, A. T. F., & Penninx, B. W. J. H. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.137 · Cited by 114
Scaini, G., Valvassori, S. S., Díaz, A. P., Lima, C. N. D. C., Benevenuto, D., Fries, G. R., & Quevedo, J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0732 · Cited by 135
Owens, M., Herbert, J., Jones, P. B., Sahakian, B. J., Wilkinson, P. O., Dunn, V. J., Croudace, T. J., & Goodyer, I. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318786111 · Cited by 101
The HPA Axis as Target for Depression
Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131
“Alterations in the HPA axis are robustly found in MDD [33, 34], mostly in terms of HPA axis hyperactivity due to an impaired sensitivity to negative feedback regulation [35, 36].”
BackgroundResultLiu, S., Guo, R., Liu, F., Yuan, Q., Yu, Y., & Ren, F. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s243551 · Cited by 130
“HPA axis hyperactivity is a hypothesis that has been accepted in depression research, which mainly manifests as excessive CORT secretion.(40) It was found that > 50% of patients with severe depression have maladjusted negative feedback regulation of the HPA axis with progressively increasing circulating CORT and ACTH…”
BackgroundThe Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
Almeida, F. B., Pinna, G., & Barros, H. M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115495 · Cited by 130
“About 30% of depressed individuals display higher levels of cortisol [10,11], and subjects in remission present levels comparable to healthy, never-depressed controls [12].”
BackgroundSpencer, S. J., Emmerzaal, T. L., Kozicz, T., & Andrews, Z. B. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.021 · Cited by 129
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 131
Cardiovascular disease and depression: a narrative review
Li, X., Zhou, J., Wang, M., Yang, C., & Sun, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1274595 · Cited by 129
A review of selected candidate endophenotypes for depression
Goldstein, B. L., & Klein, D. N. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.06.003 · Cited by 128
“Cortisol is relevant to depression since it is linked to lab-induced acute and chronic stress (e.g. Burke, Davis, Otte, & Mohr, 2005; Stetler & Miller 2011) and may be a pathway for depression transmission (Halligan, Herbert, Goodyer, & Murray, 2007).”
BackgroundCarniel, B. P., & da Rocha, N. S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110151 · Cited by 127
Maciaszek, J., Ciułkowicz, M., Misiak, B., Szcześniak, D. M., Łuc, D., Wieczorek, T., Fila-Witecka, K., Gawłowski, P., & Rymaszewska, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082527 · Cited by 130
Kerling, A., Tegtbur, U., Guetzlaff, E., Kück, M., Borchert, L., Ateş, Z., von Bohlen, A., Frieling, H., Hüper, K., Hartung, D., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.006 · Cited by 127
Increased Serum Levels of Cortisol and Inflammatory Cytokines in People With Depression
Jia, Y., Liu, L., Sheng, C., Cheng, Z., Cui, L., Li, M., Zhao, Y., Shi, T., Yau, T. O., Li, F., et al. (2019) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000957 · Cited by 106
Depression Among Older Adults with Diabetes Mellitus
Park, M., & Reynolds, C. F. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.022 · Cited by 126
Stress and excitatory synapses: From health to disease
Timmermans, W., Xiong, H., Hoogenraad, C. C., & Krugers, H. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.043 · Cited by 133
“For example, if the stress response is inadequate or excessive and prolonged, the hypersecretion of corticosteroids increases the risk for depression (Stetler and Miller, 2011).”
Childhood trauma, HPA axis activity and antidepressant response in patients with depression
Nikkheslat, N., McLaughlin, A. P., Hastings, C., Zajkowska, Z., Nettis, M. A., Mariani, N., Enache, D., Lombardo, G., Pointon, L., Cowen, P. J., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.11.024 · Cited by 124
Hu, B., Das, P., Lv, X., Shi, M., Aa, J., Wang, K., Duan, L., Gilbert, J. A., Nie, Y., & Wu, X. (2022) · mSystems · doi:10.1128/msystems.00218-22 · Cited by 124
“Its etiology involves impaired regulatory mechanisms of neuroendocrine, immune, and neurotransmitter systems (1).”
BackgroundAn affective neuroscience model of boosting resilience in adults
Tabibnia, G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.005 · Cited by 104
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Fu, X., Wang, Y., Zhao, F., Cui, R., Xie, W., Liu, Q., & Yang, W. (2023) · Aging · doi:10.18632/aging.204847 · Cited by 124
Comorbidity Factors and Brain Mechanisms Linking Chronic Stress and Systemic Illness
Duric, V., Clayton, S., Leong, M. L., & Yuan, L.-L. (2016) · Neural Plasticity · doi:10.1155/2016/5460732 · Cited by 98
“For example, approximately two-thirds of patients suffering from depression exhibit elevated cortisol levels [215].”
BackgroundThe molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Animal models for the study of depressive disorder
Song, J., & Kim, Y. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13622 · Cited by 124
The effect of prenatal Hatha yoga on affect, cortisol and depressive symptoms
Bershadsky, S., Trumpfheller, L., Kimble, H. B., Pipaloff, D., & Yim, I. S. (2014) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2014.01.002 · Cited by 119
“cortisol levels [22], an increased cortisol response to awakening [23e27] and poorer cortisol recovery after psychological stress [28].”
Neurogenetics of depression: A focus on reward processing and stress sensitivity
Bogdan, R., Nikolova, Y. S., & Pizzagalli, D. A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.007 · Cited by 106
“Moreover, in support of the relationship between stress and anhedonia, HPA axis dysfunction is particularly prevalent in individuals with melancholic depression, a severe subtype characterized by anhedonia (Gold and Chrousos, 1999; Gold et al., 2002; Pintor et al., 2007; Stetler and Miller, 2011).”
Psilocybin for treating substance use disorders?
de Veen, B. T. H., Schellekens, A. F. A., Verheij, M. M. M., & Homberg, J. R. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1220834 · Cited by 99
“Early life adversity and aberrant function of the HPA-axis have also been associated with MDD [79] and SUD [80], although the precise mechanisms are not fully clear yet.”
BackgroundDelineating the Genetic Component of Gene Expression in Major Depression
Dall’Aglio, L., Lewis, C. M., & Pain, O. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.09.010 · Cited by 118
Understanding Familial Risk for Depression: A 25-Year Perspective
Gotlib, I. H., Joormann, J., & Foland-Ross, L. C. (2014) · Perspectives on Psychological Science · doi:10.1177/1745691613513469 · Cited by 104
Gobinath, A. R., Mahmoud, R., & Galea, L. A. M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00420 · Cited by 104
“…and postpartum are characterized by sustained high flattened levels of glucocorticoids in both humans (Magiakou et al., 1996; Schule, 2007) and rodents (Lightman et al., 2001; Pawluski et al., 2009), which is a similar hormone profile observed in depressed patients (Stetler and Miller, 2011).”
BackgroundFischer, S., Doerr, J. M., Strahler, J., Mewes, R., Thieme, K., & Nater, U. M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.018 · Cited by 114
Vinkers, C. H., Kuzminskaite, E., Lamers, F., Giltay, E. J., & Penninx, B. W. J. H. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.051 · Cited by 113
Association between suicidal behaviour and impaired glucose metabolism in depressive disorders
Koponen, H., Kautiainen, H., Leppänen, E., Mäntyselkä, P., & Vanhala, M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0567-x · Cited by 102
“Higher cortisol levels are associated with age and more severe forms of depression, such as melancholic and psychotic depression, and may thus also contribute to the association between higher BDI levels and risk of suicidal behavior [33, 34].”
BackgroundPrins, J., Olivier, B., & Korte, S. M. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594039 · Cited by 97
“Such a link is the strongest among older inpatients who display melancholic depression (including psychotic features) [81].”
BackgroundFischer, S., Strawbridge, R., Vives, A. H., & Cleare, A. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.180653 · Cited by 112
“Importantly, however, our findings may not be applicable to patients with atypical depression, who have been found to present with low rather than high cortisol values (7).”
BackgroundMedina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 101
Modified Cortisol Circadian Rhythm: The Hidden Toll of Night-Shift Work
Andreadi, A., Andreadi, S., Todaro, F., Ippoliti, L., Bellia, A., Magrini, A., Chrousos, G. P., & Lauro, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052090 · Cited by 112
“Studies have identified elevated evening cortisol levels and blunted morning rises as biomarkers of major depressive disorder [56].”
Kozela, M., Bobak, M., Besala, A., Micek, A., Kubinova, R., Malyutina, S., Denisova, D., Richards, M., Pikhart, H., Peasey, A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316649493 · Cited by 96
Salivary cortisol in early psychosis: New findings and meta-analysis
Chaumette, B., Kébir, O., Mam-Lam-Fook, C., Morvan, Y., Bourgin, J., Godsil, B. P., Plaze, M., Gaillard, R., Jay, T. M., & Krebs, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.007 · Cited by 110
Majidi, J., Kosari-Nasab, M., & Salari, A.-A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.10.009 · Cited by 109
Horchar, M. J., & Wohleb, E. S. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.030 · Cited by 98
Treatment-Resistant Depression Revisited: A Glimmer of Hope
Halaris, A. E., Sohl, E., & Whitham, E. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020155 · Cited by 110
“As mentioned in the HPA axis section above, elevated cortisol is among the most robust pathophysiological findings in mood disorders [17].”
BackgroundInfluentialSalivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia
Geerlings, M. I., Sigurdsson, S., Eiriksdottir, G., Garcia, M. E., Harris, T. B., Gudnason, V., & Launer, L. J. (2015) · Neurology · doi:10.1212/wnl.0000000000001931 · Cited by 92
Nolan, M., Roman, E., Nasa, A., Levins, K. J., O’Hanlon, E., O’Keane, V., & Willian Roddy, D. (2020) · Chronic Stress · doi:10.1177/2470547020944553 · Cited by 107
“This finding has been widely replicated with a majority of studies indicating HPA-axis overactivity, perhaps underpinning the association between MDD and chronic metabolic and neurodegenerative diseases.(18,80,81) HPA activity depends on balanced integration of amygdalar activation and hippocampal inhibition of the pe…”
ResultNeuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression
Neupane, S. P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00655 · Cited by 107
“Hypothalamic–pituitary–adrenal-axis hyperactivity and glucocorticoid receptor impairment are reliable findings in depression (91), and altered HPA axis regulation is a hallmark of hormonal dysbalance in AUD (92).”
BackgroundSix-year longitudinal course and outcomes of subtypes of depression
Lamers, F., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.153098 · Cited by 94
Wilkinson, P. O., & Goodyer, I. M. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000472 · Cited by 86
The interface of stress and the HPA axis in behavioural phenotypes of mental illness
Baumeister, D., Lightman, S. L., & Pariante, C. M. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_304 · Cited by 104
“…cortisol and ACTH but not CRH levels, individual subtypes differed: atypical depression was associated with a third of a standard deviation (SD) lower, melancholic depression a quarter of an SD higher, and psychotic depression nearly half an SD higher cortisol levels (Stetler and Miller 2011).”
BackgroundCeramides and depression: A systematic review
Dinoff, A., Herrmann, N., & Lanctôt, K. L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.008 · Cited by 105
Moreira, F. P., Jansen, K., Cardoso, T. D. A., Mondin, T. C., Magalhães, P. V. D. S., Kapczinski, F. P., Souza, L. D. D. M., da Silva, R. A., Oses, J. P., & Wiener, C. D. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.025 · Cited by 104
Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism
Li, M., Yao, X., Sun, L., Zhao, L., Xu, W., Zhao, H., Zhao, F., Zou, X., Cheng, Z., Li, B., et al. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00080 · Cited by 104
Depression and cardiovascular disease: an update on how course of illness may influence risk
Fiedorowicz, J. G. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0492-6 · Cited by 103
“HPA dysregulation may also be more pronounced in older adults with depression [43, 44].”
BackgroundPinto, J. V., Moulin, T. C., & Amaral, O. B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.001 · Cited by 103
“, 2015a), IL-6 and cortisol in depression (Haapakoski et al., 2015; Stetler and Miller, 2011), CRP and positive symptoms in schizophrenia (Fernandes et al.”
Hinkelmann, K., Moritz, S., Botzenhardt, J., Muhtz, C., Wiedemann, K., Kellner, M., & Otte, C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.012 · Cited by 103
The psychoneuroimmunology of pregnancy
Sherer, M. L., Posillico, C. K., & Schwarz, J. M. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.10.006 · Cited by 102
Gerritsen, L., Milaneschi, Y., Vinkers, C. H., van Hemert, A. M., van Velzen, L. S., Schmaal, L., & Penninx, B. W. J. H. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.118 · Cited by 104
“A maladaptive stress response or dysregulation of the hypothalamus pituitary adrenal (HPA)-axis is a frequent finding in MDD; a meta-analysis showed that MDD patients overall have higher levels of cortisol (Stetler and Miller, 2011).”
BackgroundBeyond Glucocorticoids: Integrating Dehydroepiandrosterone (DHEA) into Animal Welfare Research
Whitham, J. C., Bryant, J. L., & Miller, L. J. (2020) · Animals · doi:10.3390/ani10081381 · Cited by 101
The cortisol axis and psychiatric disorders: an updated review
George, M. Y., Mageed, S. S. A., Mansour, D. E., & Fawzi, S. F. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00782-x · Cited by 101
“…most primarily reported HPA axis changes related with depression included suppressed cortisol circadian rhythms with higher levels late in the day [ 120 ], negative feedback insensitivity, as characterized by inability of morn - ing cortisol suppression after dexamethasone administration [ 121 ],…”
Social deprivation and the HPA axis in early development
Koss, K. J., Hostinar, C. E., Donzella, B., & Gunnar, M. R. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.028 · Cited by 99
Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
Lok, A., Mocking, R. J. T., Ruhé, H. G., Visser, I., Koeter, M. W. J., Assies, J., Bockting, C. L. H., Olff, M., & Schene, A. H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.10.005 · Cited by 99
“…cortisol (Vreeburg et al., 2009a; Knorr et al., 2010), reduced feedback from glucocorticoids (Pariante and Miller, 2001), and enlarged endocrine glands (Rubin et al., 1995), resulted in a general consensus of an HPAaxis overdrive in patients with more severe forms of MDD (Stetler and Miller, 2011).”
Iob, E., Lacey, R. E., & Steptoe, A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.019 · Cited by 99
“Elevated levels of these biomarkers have been implicated in the pathogenesis of several mental and physical health problems such as depression, cardiovascular disease, and diabetes (Acabchuk et al., 2017; Baumeister et al., 2014; Belvederi Murri et al., 2014; Girod and Brotman, 2004; Haapakoski et al., 2015; Hackett a…”
BackgroundOgunmoroti, O., Osibogun, O., Spatz, E. S., Okunrintemi, V., Mathews, L., Ndumele, C. E., & Michos, E. D. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106891 · Cited by 84
Martemucci, G., Fracchiolla, G., Muraglia, M., Tardugno, R., Dibenedetto, R. S., & D‘Alessandro, A. G. (2023) · Antioxidants · doi:10.3390/antiox12122091 · Cited by 99
“…have shown that depressive and anxiety disorders are linked to physiological disorders such as systemic inflammation [553], oxidative stress [554], hyperactivity of the hypothalamic–pituitary–adrenal axis (HPA) [555] and dysregulated autonomous tone [556], along with an alteration of MS [552].”
Public Health Perspectives on Depressive Disorders
Cohen, N. L. (2017) · Johns Hopkins University Press eBooks · doi:10.1353/book.52762 · Cited by 99
Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms
Capuron, L., & Castanon, N. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_14 · Cited by 101
Goldman-Mellor, S. J., Hamer, M., & Steptoe, A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.010 · Cited by 99
“However, data on HPA axis functioning in depression are generally complex and often difficult to interpret, and observed effects can depend on numerous factors (Stetler and Miller, 2011).”
BackgroundDietrich, A., Ormel, J., Buitelaar, J. K., Verhulst, F. C., Hoekstra, P. J., & Hartman, C. A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.013 · Cited by 103
“, 2001) as well as adults (Knorr et al., 2010; Stetler and Miller, 2011; see also Vreeburg et al., 2009) with depressive disorders (i.”
BackgroundInfluentialHinkelmann, K., Muhtz, C., Dettenborn, L., Agorastos, A., Wingenfeld, K., Spitzer, C., Gao, W., Kirschbaum, C., Wiedemann, K., & Otte, C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.021 · Cited by 96
Cortisol and α-Amylase Secretion Patterns between and within Depressed and Non-Depressed Individuals
Booij, S. H., Bos, E. H., Bouwmans, M. E. J., van Faassen, M., Kema, I. P., Oldehinkel, A. J., & de Jonge, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131002 · Cited by 96
“In a meta-analysis, Stetler and Miller summarized four decades of research into HPA axis activation and depression, and concluded that there seems to be a tendency for increased HPA axis activation in depressed samples [5].”
BackgroundSong, J., Zhou, N., Ma, W., Gu, X., Chen, B., Zeng, Y. C., Yang, L., & Zhou, M. (2019) · Food & Function · doi:10.1039/c8fo02599a · Cited by 100
Systematic reviews on behavioural and psychological symptoms in the older or demented population
van der Linde, R. M., Stephan, B. C. M., Savva, G. M., Dening, T., & Brayne, C. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt131 · Cited by 96
“suggest an association between depression and cortisol and other hormones [46].”
InfluentialRothe, N., Steffen, J., Penz, M. S., Kirschbaum, C., & Walther, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.024 · Cited by 96
Cizza, G., Ronsaville, D. S., Kleitz, H., Eskandari, F., Mistry, S., Torvik, S., Sonbolian, N., Reynolds, J. C., Blackman, M. R., Gold, P. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028912 · Cited by 85
“A recent metaanalysis found no differences in ACTH levels in clinical subtypes [35]; however repeated sampling over 24 hours may unravel abnormalities not evident with single plasma sampling.”
BackgroundKovács, Z., D’Agostino, D. P., Diamond, D. M., Kindy, M. S., Rogers, C. Q., & Ari, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00363 · Cited by 93
“Hyperactivity of HPA system was also demonstrated (195).”
BackgroundInflammatory Pathogenesis of Post-stroke Depression
Feng, X., Ma, X., Li, J., Zhou, Q., Liu, Y., Song, J., Liu, J., Situ, Q., Wang, L., Zhang, J., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0203 · Cited by 94
“This activation is further exacerbated by cytokines released from the injured neurons, with pro-inflammatory cytokines such as IL-1, IL-6, CRP, TNF-α and IFN-γ being potent stimulators of the HPA axis [176].”
Application of antidepressants in depression: A systematic review and meta-analysis
Yuan, Z., Chen, Z., Xue, M., Zhang, J., & Leng, L. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.08.013 · Cited by 94
Melief, J., de Wit, S. J., van Eden, C. G., Teunissen, C. E., Hamann, J., Uitdehaag, B. M. J., Swaab, D. F., & Huitinga, I. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1140-7 · Cited by 93
“In disagreement with previous studies, we did not find an association of cortisol levels with lifetime occurrence of a mood disorder [48].”
Structure of major depressive disorder in adolescents and adults in the US general population
Lamers, F., Burstein, M., He, J.-P., Avenevoli, S., Angst, J., & Merikangas, K. R. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.098079 · Cited by 80
Biomarker Approaches in Major Depressive Disorder Evaluated in the Context of Current Hypotheses
Jentsch, M. C., Van Buel, E. M., Bosker, F. J., Gladkevich, A. V., Klein, H. C., Oude Voshaar, R. C., Ruhé, H. G., Eisel, U. L., & Schoevers, R. A. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.114 · Cited by 80
Zimmaro, L. A., Sephton, S. E., Siwik, C. J., Phillips, K. M., Rebholz, W. N., KRAEMER, H. C., Giese‐Davis, J., Wilson, L., Bumpous, J. M., & Cash, E. D. (2018) · Cancer · doi:10.1002/cncr.31109 · Cited by 90
Epp, J. R., Beasley, C. L., & Galea, L. A. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.132 · Cited by 88
“Older age is associated with hypercortisolemia, small hippocampal volume, and reduced SSRI efficacy in MDD patients (McKinnon et al, 2009; Parker et al, 2003a; Stetler and Miller, 2011; Thase et al, 2005).”
BackgroundVon Werne Baes, C., de Carvalho Tofoli, S. M., Martins, C. M. S., & Juruena, M. F. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00610.x · Cited by 80
Lahti, M., Eriksson, J. G., Heinonen, K., Kajantie, E., Lahti, J., Wahlbeck, K., Tuovinen, S., Pesonen, A.-K., Mikkonen, M., Osmond, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291714001998 · Cited by 77
“…stress system has been found among patients with different mental disorders, for example among patients with depression (Vreeburg et al. 2010; Stetler & Miller, 2011; Carvalho Fernando et al. 2012), anxiety disorders (Ipser et al. 2013), post-traumatic stress disorder (Morris et al. 2012;…”
BackgroundLattice Boltzmann Method for Fluid-Thermal Systems: Status, Hotspots, Trends and Outlook
Li, L., Wan, Y., Lu, J., Fang, H., Yin, Z., Wang, T., Wang, R., Fan, X., Zhao, L., & Tan, D. (2020) · IEEE Access · doi:10.1109/access.2020.2971546 · Cited by 86
Metadata
- Authors
- Stetler, C., & Miller, G. E.
- Affiliations
- Furman University (US)
- University of British Columbia (CA)
- Corresponding author
- Stetler, Cinnamon
- ORCID
- Miller, Gregory E.
- Venue
- Psychosomatic Medicine
- Published
- 2011-02
- Volume
- 73
- Issue
- 2
- Pages
- 114-126
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2325341530
- Semantic Scholar
- 8dd36c89fdc21f4d365839c99e1ae8e38ebdcccb
- Cited by
- 1,123
- References
- 32
- Citations by year
- 2026: 54 · 2025: 62 · 2024: 56 · 2023: 84 · 2022: 96 · 2021: 100 · 2020: 90 · 2019: 85 · 2018: 81 · 2017: 69 · 2016: 95 · 2015: 70 · 2014: 61 · 2013: 59 · 2012: 40
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, hypothalamic-pituitary-adrenal axis, cortisol, ACTH, corticotropin-releasing factor, atypical depression, endogenous depression, psychotic depression, hospitalized older adults, methodological quality, gender differences
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Child, Corticotropin-Releasing Hormone, Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Research, Bibliometrics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.